• head_banner_01

Proteinni sintez qilish uchun ishlatiladigan aminokislotalarning aralashmalari

Qisqa Tasvir:

NO

Mahsulotlar

CAS raqami

1

Fmoc-D-Ala-D-Ala-OH

NA

2

Fmoc-b-Ala-D-Ala-OH

NA

3

Fmoc-Arg(pbf)-Arg(pbf)-OH

NA


Mahsulot detali

Mahsulot teglari

Mahsulot detali

NO

Mahsulotlar

CAS raqami

Asosiy sifat ko'rsatkichi

Tozalik

Maks.

nopoklik

Umumiy erituvchi qoldig'i

Namlik

1

Fmoc-b-Ala-Ala-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

2

Fmoc-D-Ala-D-Ala-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

3

Fmoc-b-Ala-D-Ala-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

4

Fmoc-Arg(pbf)-Arg(pbf)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

5

Fmoc-b-Ala-Arg(pbf)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

6

Fmoc-D-Arg(pbf)-D-Arg(pbf)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

7

Fmoc-b-Ala-D-Arg(pbf)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

8

Fmoc-HomoArg(pbf)-HomoArg(pbf)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

9

Fmoc-b-Ala-HomoArg(pbf)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

10

Fmoc-Asn(Trt)-Asn(Trt)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

11

Fmoc-b-Ala-Asn(Trt)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

12

Fmoc-Asp(OtBu)-Asp(OtBu)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

13

Fmoc-b-Ala-Asp(OtBu)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

14

Fmoc-Cys(Trt)-Cys(Trt)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

15

Fmoc-b-Ala-Cys(Trt)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

16

Fmoc-Cys(Acm)-Cys(Acm)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

17

Fmoc-b-Ala-Cys(Acm)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

18

Fmoc-Gln(Trt)-Gln(Trt)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

19

Fmoc-b-Ala-Gln(Trt)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

20

Fmoc-Glu(OtBu)-Glu(OtBu)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

21

Fmoc-b-Ala-Glu(OtBu)-OH.H2O

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

22

Fmoc-b-Ala-Gly-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

23

Fmoc-His(Trt)-His(Trt)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

24

Fmoc-b-Ala-His(Trt)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

25

Fmoc-Ile-Ile-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

26

Fmoc-b-Ala-Ile-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

27

Fmoc-Leu-Leu-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

28

Fmoc-b-Ala-Leu-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

29

Fmoc-D-Leu-D-Leu-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

30

Fmoc-b-Ala-D-Leu-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

31

Fmoc-Lys(Boc)-Lys(Boc)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

32

Fmoc-b-Ala-Lys(Boc)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

33

Fmoc-Lys(Alloc)-Lys(Alloc)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

34

Fmoc-b-Ala-Lys(Alloc)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

35

Fmoc-Met-Met-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

36

Fmoc-b-Ala-Met-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

37

Fmoc-Orn(Boc)-Orn(Boc)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

38

Fmoc-b-Ala-Orn(Boc)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

39

Fmoc-Phe-Phe-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

40

Fmoc-b-Ala-Phe-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

41

Fmoc-D-Phe-D-Phe-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

42

Fmoc-b-Ala-D-Phe-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

43

Fmoc-Pro-Pro-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

44

Fmoc-b-Ala-Pro-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

45

Fmoc-Ser(tBu)-Ser(tBu)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

46

Fmoc-b-Ala-Ser(tBu)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

47

Fmoc-Ser(Trt)-Ser(Trt)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

48

Fmoc-b-Ala-Ser(Trt)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

49

Fmoc-Thr(tBu)-Thr(tBu)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

50

Fmoc-b-Ala-Thr(tBu)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

51

Fmoc-Trp(Boc)-Trp(Boc)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

52

Fmoc-b-Ala-Trp(Boc)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

53

Fmoc-D-Trp(Boc)-D-Trp(Boc)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

54

Fmoc-b-Ala-D-Trp(Boc)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

55

Fmoc-Tyr(tBu)-Tyr(tBu)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

56

Fmoc-b-Ala-Tyr(tBu)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

57

Fmoc-D-Tyr(Et)-D-Tyr(Et)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

58

Fmoc-b-Ala-D-Tyr(Et)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

59

Fmoc-Tyr(Men)-Tyr(Men)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

60

Fmoc-b-Ala-Tyr(Me)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

61

Fmoc-Val-Val-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

62

Fmoc-b-Ala-Val-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

63

Fmoc-D-Cit-D-Cit-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

64

Fmoc-b-Ala-D-Cit-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

65

Fmoc-b-Ala-Dab-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

66

Fmoc-(3-(2-naftil)-D-Ala)2-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

67

Fmoc-b-Ala-3-(2-naftil)-D-Ala-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

68

Fmoc-(3-(3-piridinil)-D-Ala)2-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

69

Fmoc-b-Ala-3-(3-piridinil)-D-Ala-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

70

Fmoc-(4-xloro-D-Phe)2-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

71

Fmoc-b-Ala-4-xloro-D-Phe-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

72

Fmoc-(D-4Aph(tBuCbm))2-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

73

Fmoc-b-Ala-D-4Aph(tBuCbm)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

74

Fmoc-Aph(L-Hor)-Aph(L-Hor)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

75

Fmoc-b-Ala-Aph(L-Hor)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

76

Fmoc-Lys(iPr,Boc)-Lys(iPr,Boc)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

77

Fmoc-b-Ala-Lys(iPr,Boc)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

78

Fmoc-b-Ala-AEEA-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

79

Fmoc-Aib-Aib-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

80

Fmoc-b-Ala-Aib-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

81

Fmoc-Arg-OH

91000-69-0

≥98,0%

≤1,0%

≤8,0%

≤2,0%

82

H-Arg(pbf)-OH

200115-86-2

≥98,0%

≤1,0%

≤8,0%

≤2,0%

83

Fmoc-D-Arg-OH

130752-32-8

≥98,0%

≤1,0%

≤8,0%

≤2,0%

84

HD-Arg(pbf)-OH

200116-81-0

≥98,0%

≤1,0%

≤8,0%

≤2,0%

85

Fmoc-HomoArg-OH.HCl

208174-14-5

≥98,0%

≤1,0%

≤8,0%

≤2,0%

86

H-HomoArg(pbf)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

87

Fmoc-D-HomoArg-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

88

HD-HomoArg(pbf)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

89

Fmoc-Asn-OH

71989-16-7

≥98,0%

≤1,0%

≤8,0%

≤2,0%

90

H-Asn(Trt)-OH

132388-58-0

≥98,0%

≤1,0%

≤8,0%

≤2,0%

91

Fmoc-Asp-OH

119062-05-4

≥98,0%

≤1,0%

≤8,0%

≤2,0%

92

H-Asp(OtBu)-OH

3057-74-7

≥98,0%

≤1,0%

≤8,0%

≤2,0%

93

Fmoc-Cys-OH

135248-89-4

≥98,0%

≤1,0%

≤8,0%

≤2,0%

94

H-Cys(Trt)-OH

2799/7/7

≥98,0%

≤1,0%

≤8,0%

≤2,0%

95

H-Cys(Acm)-OH.HCl

28798-28-9

≥98,0%

≤1,0%

≤8,0%

≤2,0%

96

Fmoc-Gln-OH

71989-20-3

≥98,0%

≤1,0%

≤8,0%

≤2,0%

97

H-Gln(Trt)-OH

102747-84-2

≥98,0%

≤1,0%

≤8,0%

≤2,0%

98

Fmoc-Glu-OH

121343-82-6

≥98,0%

≤1,0%

≤8,0%

≤2,0%

99

H-Glu(OtBu)-OH.H2O

2419-56-9

≥98,0%

≤1,0%

≤8,0%

≤2,0%

100

Fmoc-His-OH

116611-64-4

≥98,0%

≤1,0%

≤8,0%

≤2,0%

101

H-His(Trt)-OH

35146-32-8

≥98,0%

≤1,0%

≤8,0%

≤2,0%

102

Boc-His-OH

17791-52-5

≥98,0%

≤1,0%

≤8,0%

≤2,0%

103

Fmoc-Lys-OH

105047-45-8

≥98,0%

≤1,0%

≤8,0%

≤2,0%

104

H-Lys(Boc)-OH

2418-95-3

≥98,0%

≤1,0%

≤8,0%

≤2,0%

105

H-Lys (Alloc) -OH

6298/3/9

≥98,0%

≤1,0%

≤8,0%

≤2,0%

106

Fmoc-Orn-OH.HCl

201046-57-3

≥98,0%

≤1,0%

≤8,0%

≤2,0%

107

H-Orn(Boc)-OH

13650-49-2

≥98,0%

≤1,0%

≤8,0%

≤2,0%

108

Fmoc-Ser-OH

73724-45-5

≥98,0%

≤1,0%

≤8,0%

≤2,0%

109

H-Ser(tBu)-OH

18822-58-7

≥98,0%

≤1,0%

≤8,0%

≤2,0%

110

H-Ser(Trt)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

111

Fmoc-Thr-OH.H2O

73731-37-0

≥98,0%

≤1,0%

≤8,0%

≤2,0%

112

H-Thr(tBu)-OH

4378-13-6

≥98,0%

≤1,0%

≤8,0%

≤2,0%

113

Fmoc-Trp-OH

35737-15-6

≥98,0%

≤1,0%

≤8,0%

≤2,0%

114

H-Trp(Boc)-OH

146645-63-8

≥98,0%

≤1,0%

≤8,0%

≤2,0%

115

Fmoc-D-Trp-OH

86123-11-7

≥98,0%

≤1,0%

≤8,0%

≤2,0%

116

HD-Trp(Boc)-OH

2012-yil 90-11-1

≥98,0%

≤1,0%

≤8,0%

≤2,0%

117

Fmoc-Tyr-OH

92954-90-0

≥98,0%

≤1,0%

≤8,0%

≤2,0%

118

H-Tir(tBu)-OH

18822-59-8

≥98,0%

≤1,0%

≤8,0%

≤2,0%

119

Fmoc-D-Tyr-OH

112883-29-1

≥98,0%

≤1,0%

≤8,0%

≤2,0%

120

HD-Tyr(Et)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

121

H-Tyr(Me)-OH.HCl

67423-44-3

≥98,0%

≤1,0%

≤8,0%

≤2,0%

122

Fmoc-D-4Aph(Cbm)-OH

324017-22-3

≥98,0%

≤1,0%

≤8,0%

≤2,0%

123

HD-4Aph(tBuCbm)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

124

Fmoc-Lys(iPr)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

125

H-Lys(iPr,Boc)-OH

NA

≥98,0%

≤1,0%

≤8,0%

≤2,0%

Haqida

Kompensatsiya

Gentolex yuqori sifatli mahsulotlarni taqdim etadi, agar biron bir mahsulot sifati mijoz tomonidan kerakli vaqt oralig'ida etarli dalillar bilan ko'tarilsa, biz kompensatsiya protseduralarini boshlash uchun zarur tahlil va baholashni taqdim etamiz.

Ishlab chiqarish

Farmatsevtika mahsulotlarining quvvati tonna darajaga yetdi, kimyoviy mahsulotlarning quvvati 100 tonna+ navga yetdi, imkoniyatlar butun dunyo bo'ylab mijozlarga xizmat ko'rsatish uchun yaxshi jihozlangan.

Tadqiqot va ishlanmalar

Har yili ilmiy-tadqiqot guruhi tomonidan turli xil yangi mahsulotlarni ishlab chiqish rejasi ishlab chiqiladi, maqsadlar qo'yilganda, jamoaning har bir a'zosi KPI mas'uliyati va rag'batlantirish siyosatini olib borishi kerak.


  • Oldingi:
  • Keyingisi:

  • Xabaringizni shu yerga yozing va bizga yuboring